fbpx

Research

NANEXA: Insights from CMD underscore near- to mid-term opportunities with significant potential

Analys, Research

Apart from a slight further delay in the start of Phase I with NEX-22, the report for Q1’24 proved rather uneventful. The subsequent CMD...

Read More

GRANGEX: Striking renegotiation of Sydvaranger acquisition setting GRANGEX up for an eventful 2024

Analys, Research

With a striking renegotiation of the final purchase agreement for Sydvaranger, reducing the initial payment from USD 1+19m to USD 1+0.5m,...

Read More

MOTION DISPLAY: Another strong quarter confirming that MODI has turned the corner

Analys, Research

MODI reported sales growth in Q1’24 of 31%, confirming that the strong momentum seen in H2’23 carried into 2024. Along with a 4ppt...

Read More

CRUNCHFISH: Broadening of scope to all offline credentials

Analys, Research

Johan Widmark | 2024-05-03 12:00  READ FULL REPORT IN PDF HERE Following the app-integrated offline payments with Digital Cash, and recent...

Read More

PROLIGHT: Important milestone amidst mixed news flow

Analys, Research

There has been a somewhat mixed news flow from Prolight after the close of Q1’24. The finalization of the cartridge design to be used on...

Read More

CRUNCHFISH: Major TAM expansion with broadening to secure and scalable mobile card payments

Analys, Research

Johan Widmark | 2024-03-27 12:00  READ FULL REPORT IN PDF HERE With the broadening of its Digital Cash technology to support secure...

Read More

PROLIGHT: PoC troponin testing ready for next step

Analys, Research

With proof-of-performance for its proprietary digital technique for detection of high-sensitive biomarkers even in whole blood, Prolight...

Read More

GRANGEX: Starting to fuel up: GRANGEX set for busy agenda in 2024 

Analys, Research

With the SEK 74 m (estimated 61m net) proceeds from the rights issue, we now look forward to the updated feasibility study initiated in...

Read More

NANEXA: Focus on dual GLP-1 opportunities and the partner projects

Analys, Research

Apart from a write down of capitalized development related to the suspended projects NEX-18 and NEX-20, there was not much new in...

Read More

FREE2MOVE: Growth and improved focus on profitability catalysts for steep revaluation

Analys, Research

As expected, Free2Move reported solid growth in Q4, achieving a 59% growth rate for the full year. However, foreign exchange (FX)...

Read More

For new research on growth stocks, sign up to our newsletter